Cancer therapy with checkpoint inhibitors: Establishing a role for ophthalmology Journal Article

  


Authors: Davis, M. E.; Francis, J. H.
Article Title: Cancer therapy with checkpoint inhibitors: Establishing a role for ophthalmology
Abstract: Objective To discuss interprofessional collaboration between the primary oncology clinicians and specialists in the management of immune-related ocular toxicities. Data Sources Peer-reviewed articles, case reports and systematic reviews. Conclusion Accurate ophthalmologic assessment is critical for the prevention and treatment of ocular toxicities associated with immunotherapy. Implications for Nursing Practice Oncology nurses play a key role in early identification and management of ocular symptoms from immunotherapy; early referral to ophthalmic specialists can enhance recovery and preserve sight. © 2017 Elsevier Inc.
Keywords: immunotherapy; toxicity; management; eye; checkpoint inhibitor; interprofessional collaboration
Journal Title: Seminars in Oncology Nursing
Volume: 33
Issue: 4
ISSN: 0749-2081
Publisher: Elsevier Inc.  
Date Published: 2017-11-01
Start Page: 415
End Page: 424
Language: English
DOI: 10.1016/j.soncn.2017.08.003
PROVIDER: scopus
PUBMED: 28941564
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029578801&doi=10.1016%2fj.soncn.2017.08.003&partnerID=40&md5=6859c2495b2eddbb2983b7cf869099dc
Notes: Review -- Export Date: 1 December 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Jasmine Helen Francis
    257 Francis
  2. Mary Elizabeth Davis
    49 Davis
Related MSK Work